BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 15653644)

  • 1. Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality.
    Elmén J; Thonberg H; Ljungberg K; Frieden M; Westergaard M; Xu Y; Wahren B; Liang Z; Ørum H; Koch T; Wahlestedt C
    Nucleic Acids Res; 2005; 33(1):439-47. PubMed ID: 15653644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LNA incorporated siRNAs exhibit lower off-target effects compared to 2'-OMethoxy in cell phenotypic assays and microarray analysis.
    Puri N; Wang X; Varma R; Burnett C; Beauchamp L; Batten DM; Young M; Sule V; Latham K; Sendera T; Echeverri C; Sachse C; Magdaleno S
    Nucleic Acids Symp Ser (Oxf); 2008; (52):25-6. PubMed ID: 18776235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of small interfering RNAs modified by unlocked nucleic acid (UNA) to inhibit the heart-pathogenic coxsackievirus B3.
    Werk D; Wengel J; Wengel SL; Grunert HP; Zeichhardt H; Kurreck J
    FEBS Lett; 2010 Feb; 584(3):591-8. PubMed ID: 20005874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LNA-antisense rivals siRNA for gene silencing.
    Jepsen JS; Wengel J
    Curr Opin Drug Discov Devel; 2004 Mar; 7(2):188-94. PubMed ID: 15603252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and sequence motifs of siRNA linked with in vitro down-regulation of morbillivirus gene expression.
    de Almeida RS; Keita D; Libeau G; Albina E
    Antiviral Res; 2008 Jul; 79(1):37-48. PubMed ID: 18394725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locked nucleic acids: promising nucleic acid analogs for therapeutic applications.
    Veedu RN; Wengel J
    Chem Biodivers; 2010 Mar; 7(3):536-42. PubMed ID: 20232325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA.
    Vester B; Wengel J
    Biochemistry; 2004 Oct; 43(42):13233-41. PubMed ID: 15491130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of affinity constants of locked nucleic acid (LNA) and DNA duplex formation using label free sensor technology.
    Möhrle BP; Kumpf M; Gauglitz G
    Analyst; 2005 Dec; 130(12):1634-8. PubMed ID: 16284662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2'-O-Lysylaminohexyl oligonucleotides: modifications for antisense and siRNA.
    Winkler J; Gilbert M; Kocourková A; Stessl M; Noe CR
    ChemMedChem; 2008 Jan; 3(1):102-10. PubMed ID: 17979170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic potential of LNA-modified siRNAs: reduction of off-target effects by chemical modification of the siRNA sequence.
    Fluiter K; Mook OR; Baas F
    Methods Mol Biol; 2009; 487():189-203. PubMed ID: 19301648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent single stranded RNA inhibition.
    Koch T
    Nucleic Acids Symp Ser (Oxf); 2008; (52):45. PubMed ID: 18776245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites.
    Du Q; Thonberg H; Wang J; Wahlestedt C; Liang Z
    Nucleic Acids Res; 2005; 33(5):1671-7. PubMed ID: 15781493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ analysis of single-stranded and duplex siRNA integrity in living cells.
    Raemdonck K; Remaut K; Lucas B; Sanders NN; Demeester J; De Smedt SC
    Biochemistry; 2006 Sep; 45(35):10614-23. PubMed ID: 16939213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of locked nucleic acid-modified small interfering RNA in vitro and in vivo.
    Mook OR; Baas F; de Wissel MB; Fluiter K
    Mol Cancer Ther; 2007 Mar; 6(3):833-43. PubMed ID: 17363479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A protocol for designing siRNAs with high functionality and specificity.
    Birmingham A; Anderson E; Sullivan K; Reynolds A; Boese Q; Leake D; Karpilow J; Khvorova A
    Nat Protoc; 2007; 2(9):2068-78. PubMed ID: 17853862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing.
    Bartlett DW; Davis ME
    Biotechnol Bioeng; 2007 Jul; 97(4):909-21. PubMed ID: 17154307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional comparison of single- and double-stranded siRNAs in mammalian cells.
    Xu Y; Linde A; Larsson O; Thormeyer D; Elmen J; Wahlestedt C; Liang Z
    Biochem Biophys Res Commun; 2004 Apr; 316(3):680-7. PubMed ID: 15033453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choice of the adequate detection time for the accurate evaluation of the efficiency of siRNA-induced gene silencing.
    Choi I; Cho BR; Kim D; Miyagawa S; Kubo T; Kim JY; Park CG; Hwang WS; Lee JS; Ahn C
    J Biotechnol; 2005 Nov; 120(3):251-61. PubMed ID: 16095743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. siRNAdb: a database of siRNA sequences.
    Chalk AM; Warfinge RE; Georgii-Hemming P; Sonnhammer EL
    Nucleic Acids Res; 2005 Jan; 33(Database issue):D131-4. PubMed ID: 15608162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The consideration of synthetic short interfering RNA for therapeutic use.
    Li J; Liang Z
    Basic Clin Pharmacol Toxicol; 2010 Jan; 106(1):22-9. PubMed ID: 19663819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.